April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

April 02, 2025

Study Updates Diabetic Retinal Disease Prevalence and Incidence Data

The most recent studies on this data are at least 15 years old and do not reflect the changing landscape of treatments and technology

Conexiant

March 27, 2025

PPARG Shows Promise for Diabetic Retinopathy

The protective effect of PPARG on background diabetic retinopathy and proliferative diabetic retinopathy was largely mediated by glucose control.

Conexiant

March 18, 2025

FDA Approves Expanded Label for ILUVIEN

The fluocinolone acetonide intravitreal implant is now indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, as well as DME.

Conexiant

March 06, 2025

Private Equity Acquisitions Affect Industry Payments for Ophthalmologists

“It is unknown whether PE firms affect the financial incentives offered to physicians by other industry actors, which may change clinical decision-making," researchers note.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant